Alexander Hardy Salary and Compensation - BIOMARIN PHARMACEUTICAL INC CEO Pay 2024

In fiscal year 2024, Alexander Hardy, President and CEO of BIOMARIN PHARMACEUTICAL INC (BMRN), received total compensation of $14.9 million.

Alexander Hardy's compensation breakdown includes: base salary of $1.1 million, stock awards valued at $10.5 million, option awards of $1.7 million, non-equity incentive compensation of $1.5 million, and other compensation of $150K.

Compared to fiscal year 2023, Alexander Hardy's total compensation decreased 17% from $17.9 million to $14.9 million.

BIOMARIN PHARMACEUTICAL INC (BMRN) Executive Pay 2024

BIOMARIN PHARMACEUTICAL INC's top 6 named executive officers received combined total compensation of $47.7 million in fiscal year 2024.

The named executive officers disclosed in BIOMARIN PHARMACEUTICAL INC's 2024 proxy statement are:Alexander Hardy (President and CEO) with total compensation of $14.9 million, Henry J. Fuchs (M.D. Former President, Worldwide Research & Development) with total compensation of $8.1 million, Gregory R. Friberg (M.D. Executive Vice President, Chief Research & Development Officer) with total compensation of $7.2 million, Cristin Hubbard (Executive Vice President Chief Commercial Officer) with total compensation of $6.9 million, Brian R. Mueller (Executive Vice President Finance and CFO) with total compensation of $5.5 million, and G. Eric Davis (Executive Vice President Chief Legal Officer) with total compensation of $5.1 million.